Omega Therapeutics, Inc. (OMGA)

NASDAQ: OMGA · IEX Real-Time Price · USD

2.330

-0.010 (-0.43%)

At close: Apr 24, 2024, 4:00 PM

2.301

-0.029 (-1.24%)

After-hours: Apr 24, 2024, 7:40 PM EDT

Omega Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	3.09	2.07	0.14	0	0
Revenue Growth (YoY)	49.25%	1339.58%	-	-	-
Gross Profit	3.09	2.07	0.14	0	0
Selling, General & Admin	26.19	23.67	16.6	6.24	4.23
Research & Development	77.17	81.17	47.87	21.06	11.93
Other Operating Expenses	0	0	1.71	1.37	1.17
Operating Expenses	103.36	104.84	66.18	28.67	17.33
Operating Income	-100.26	-102.77	-66.03	-28.67	-17.33
Interest Expense / Income	0	0	0.91	0.78	0.6
Other Expense / Income	-2.83	-0.07	1.34	-0	0.02
Pretax Income	-97.43	-102.7	-68.28	-29.45	-17.95
Net Income	-97.43	-102.7	-68.28	-29.45	-17.95
Shares Outstanding (Basic)	54	48	22	4	13
Shares Outstanding (Diluted)	54	48	22	4	13
Shares Change	12.80%	113.71%	473.56%	-68.85%	-
EPS (Basic)	-1.80	-2.14	-3.05	-7.54	-1.43
EPS (Diluted)	-1.80	-2.14	-3.05	-7.54	-1.43
Free Cash Flow	-93.73	-99.9	-59.08	-27.94	-16.56
Free Cash Flow Per Share	-1.74	-2.09	-2.64	-7.15	-1.32
Gross Margin	100.00%	100.00%	100.00%	-	-
Operating Margin	-3240.50%	-4957.36%	-45855.56%	-	-
Profit Margin	-3148.93%	-4954.22%	-47416.67%	-	-
Free Cash Flow Margin	-3029.38%	-4818.86%	-41025.00%	-	-
EBITDA	-90.66	-97.51	-65.98	-27.52	-16.56
EBITDA Margin	-2930.09%	-4703.86%	-45821.53%	-	-
Depreciation & Amortization	6.77	5.19	1.39	1.15	0.79
EBIT	-97.43	-102.7	-67.37	-28.67	-17.35
EBIT Margin	-3148.93%	-4954.22%	-46784.72%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).